1: aspirin resistance is related to the occurrence of hypertensive disorders of pregnancy. 2: women with a history of recurrent hypertensive disorder of pregnancy develop cardiovascular risk factors more frequently than women with a history of…
ID
Bron
Verkorte titel
Aandoening
Hypertensive disorders of pregnancy
Preeclampsia
Thrombophilia
Aspirin resistance
Cardiovascular risk factors
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Aspirin resistance and cardiovascular risk factors.
Achtergrond van het onderzoek
The multicenter FRUIT-RCT demonstrated that adding low-molecular-weight heparin (LMWH) to the standard care aspirin, is beneficial in preventing early-onset hypertensive disorders of pregnancy (HD) in women with inheritable thrombophilia. Bujold et al suggested in a letter to the editor, responding to the FRUIT-RCT1 that the effect of LMWH could have been mainly beneficial in the subgroup of women who are resistant to aspirin. To evaluate this potential relationship we perform a two stage experiment: firstly evaluation of aspirin resistance in the non-pregnant FRUIT-RCT, and secondly the evaluation of aspirin resistance during pregnancy and post-puerperium. Furthermore, we want to assess the prevalence of cardiovascular risk factors in women with inheritable thrombophilia and a history of recurrent HD. We want to examine if women with a history of recurrent hypertensive disorder of pregnancy develop cardiovascular risk factors more frequently than women with a history of single HD.
Doel van het onderzoek
1: aspirin resistance is related to the occurrence of hypertensive disorders of pregnancy.
2: women with a history of recurrent hypertensive disorder of pregnancy develop cardiovascular risk factors more frequently than women with a history of single hypertensive disorder of pregnancy.
Onderzoeksopzet
Start as soon as possible.
Onderzoeksproduct en/of interventie
Participants of the previous FRUIT-RCT receive 10 days aspirin.
For the parallel study women need to have an indication for aspirin usage in pregnancy.
Publiek
Carolien Abheiden
Amsterdam 1081 HV
The Netherlands
020-444 1851
c.abheiden@vumc.nl
Wetenschappelijk
Carolien Abheiden
Amsterdam 1081 HV
The Netherlands
020-444 1851
c.abheiden@vumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Inclusion in the previous FRUIT-RCT and living in the Netherlands.
For the parallel study: indication of aspirin use during pregnancy.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Diabetes Mellitus;
Drugs that are known to alter platelet function (e.g. NSAID’s, tirofiban, eptifibatide, abciximab, clopidogrel, prasugel, ticagrelor, beta-lactam antibiotics, dextran, SSRI’s, clomipramine & amitriptyline, dipyridamole, verapamil, diltiazem , ginkgo biloba, ginseng, St John’s wort) within 2 weeks before testing.
Major surgical procedure within one week before enrollment;
Recent cardiovascular event < 3 months
Alcohol use one day before testing aspirin resistance
Abnormal cell count.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4861 |
NTR-old | NTR5106 |
CCMO | NL51093.029.14 |
OMON | NL-OMON41727 |